ECL

Ecolab

$256.61

-3.88%
Apr 29, 2026
Bobby Quantitative Model
Ecolab, Inc. is a global leader in providing water, hygiene, and infection prevention solutions and services across a diverse range of end markets, including industrial manufacturing, data centers, hospitality, healthcare, and life sciences. The company's distinct identity is built on its market-leading position, offering a comprehensive portfolio of cleaning, sanitation, and water management products that create essential, recurring revenue streams through its service-based model. The current investor narrative is heavily focused on its strategic $4.75 billion acquisition of CoolIT, a move designed to aggressively capture growth in the AI data center cooling market, though recent stock price weakness indicates investor debate over the deal's valuation and integration risks amidst a backdrop of steady core business performance.

People also watch

Sherwin-Williams

Sherwin-Williams

SHW

Analysis
Air Products & Chemicals

Air Products & Chemicals

APD

Analysis
PPG Industries

PPG Industries

PPG

Analysis
LyondellBasell

LyondellBasell

LYB

Analysis
Albemarle Corporation

Albemarle Corporation

ALB

Analysis

ECL 12-Month Price Forecast

Historical Price
Current Price $256.61
Average Target $256.61
High Target $295.1015
Low Target $218.1185

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Ecolab's 12-month outlook, with a consensus price target around $333.59 and implied upside of +30.0% versus the current price.

Average Target

$333.59

11 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

11

covering this stock

Price Range

$205 - $334

Analyst target range

Buy
3 (27%)
Hold
5 (46%)
Sell
3 (27%)

Ecolab is covered by 11 analysts, indicating substantial institutional research interest. The consensus sentiment leans bullish, with recent actions including upgrades from JP Morgan to Overweight and maintained Outperform/Buy ratings from firms like Baird, Stifel, and Jefferies. The average target price implied by the estimated EPS of $10.83 and the forward PE suggests a consensus view, though a specific average target price is not provided in the data; the implied upside must be calculated from the current price and growth expectations. The target range for estimated EPS is tight, from a low of $10.75 to a high of $10.91, signaling strong analyst conviction in near-term earnings forecasts. The high-end target likely assumes successful integration of the CoolIT acquisition, leading to accelerated growth in the high-margin data center segment and multiple expansion. The low-end target likely factors in execution risks, potential margin dilution from the deal, or a slower-than-expected contribution from new initiatives. The recent flurry of analyst activity in February and March 2026, surrounding the earnings report and acquisition news, indicates this is a focal point for debate, with the stock's performance likely hinging on the company's ability to deliver on the promised synergies and growth from this strategic shift.

Drowning in data?

Find the real signal!

Bulls vs Bears: ECL Investment Factors

The investment debate for Ecolab is finely balanced, but the bear case currently holds stronger near-term evidence due to the stock's significant price weakness and market skepticism following its major acquisition. The bull thesis rests on the company's proven profitability, strong cash flow, and the potential for the CoolIT deal to reignite growth. However, the bear thesis is supported by the stock's concrete underperformance, a premium valuation that demands flawless execution, and visible investor doubt about the acquisition's merits. The single most important tension is the market's assessment of the $4.75 billion CoolIT acquisition. Its success in accelerating growth and margins would validate the bull case and the premium multiple, while integration stumbles or a failure to meet growth targets would confirm bearish fears of overpayment and justify a valuation derating.

Bullish

  • Strong Profitability & Cash Flow: Ecolab generates robust and consistent profitability with a trailing net margin of 12.9% and an operating margin of 18.1%. The company's TTM free cash flow of $1.9 billion provides ample internal funding for growth and its recent acquisition, reducing financial risk.
  • Analyst Conviction in Forward Earnings: Coverage by 11 analysts shows strong institutional interest, with a tight consensus EPS estimate range of $10.75 to $10.91 for the coming year. Recent upgrades (e.g., JP Morgan to Overweight) signal confidence in the company's strategic direction and earnings trajectory.
  • Strategic Pivot to High-Growth AI Market: The $4.75 billion acquisition of CoolIT is a bold move to capture growth in the AI data center cooling market. If successfully integrated, this could meaningfully accelerate Ecolab's top-line growth beyond its current steady 4-5% rate and justify its premium valuation.
  • Resilient Core Business Model: The company's market-leading position in water, hygiene, and infection prevention creates essential, recurring revenue streams. This is evidenced by steady single-digit revenue growth (4.76% YoY in Q4) and a strong return on equity of 21.24%, demonstrating the durability of its core operations.

Bearish

  • Premium Valuation with High Expectations: Trading at a trailing PE of 35.83x and a forward PE of 27.81x, Ecolab commands a significant premium to typical specialty chemical peers. This high multiple leaves little room for error and increases sensitivity to any earnings disappointment or growth deceleration.
  • Market Skepticism on CoolIT Acquisition: The stock's 4.4% decline over the past three months and significant underperformance versus the S&P 500 (-7.99 relative strength) immediately following the CoolIT deal announcement suggest investor concern over the $4.75 billion price tag, integration risks, and potential margin dilution.
  • Slowing Growth in Core Business: While profitable, Ecolab's revenue growth has moderated to the mid-single digits (4.76% YoY in Q4), down from higher rates seen in parts of 2024. This tepid organic growth raises questions about whether the core business can support the current premium valuation without a successful acquisition boost.
  • Technical Weakness & Range-Bound Price: The stock is trading 13% below its 52-week high after a failed breakout attempt in February and is stuck in the middle of its annual range ($235.93-$309.27). Weak momentum, evidenced by a -7.99 three-month relative strength reading, indicates a lack of buying conviction.

ECL Technical Analysis

The prevailing price trend for Ecolab has been one of significant volatility within a defined range, culminating in a modest 12.44% gain over the past year. As of the latest close at $269.49, the stock is trading approximately 23% above its 52-week low of $235.93 and 13% below its 52-week high of $309.27, positioning it in the middle-to-upper portion of its annual range. This suggests the stock is neither in a clear momentum breakout nor a deep value zone, but rather consolidating after a failed attempt to reach new highs in February. Recent momentum has been weak, with the stock down 4.40% over the past three months and up a mere 0.35% over the past month, starkly underperforming the S&P 500 which gained 3.59% and 8.7% over the same periods, respectively. This divergence from the broader market's strength, evidenced by a -7.99 relative strength reading over three months, signals significant stock-specific headwinds, likely related to the market's reception of its major acquisition. Key technical levels are clearly defined by the 52-week high of $309.27 as major resistance and the 52-week low of $235.93 as critical support. A sustained breakout above resistance would signal a resumption of the prior uptrend and acceptance of the company's growth strategy, while a breakdown below support could indicate a deeper fundamental reassessment. The stock's beta of 1.024 indicates volatility roughly in line with the overall market, but the recent price action shows it has been acting with higher idiosyncratic risk.

Beta

Max Drawdown

-16.8%

Largest decline past year

52-Week Range

$244-$309

Price range past year

Annual Return

+3.9%

Cumulative gain past year

PeriodECL ReturnS&P 500
1m-2.2%+12.6%
3m-9.3%+2.5%
6m+0.1%+4.3%
1y+3.9%+28.4%
ytd-2.3%+4.3%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

ECL Fundamental Analysis

Ecolab's revenue trajectory shows steady, single-digit growth, with Q4 2025 revenue of $4.196 billion representing a 4.76% year-over-year increase. The multi-quarter trend reveals consistent top-line expansion, with revenue growing from $3.695 billion in Q1 2025 to the Q4 level, though growth rates have moderated from the higher levels seen in parts of 2024. The segment data highlights Global Water as the largest contributor at $2.124 billion, followed by Global Institutional and Specialty at $1.548 billion, indicating a balanced portfolio. The company is solidly profitable, reporting Q4 2025 net income of $563.9 million, translating to a net margin of 13.44%. Gross margin for the quarter was a healthy 44.03%, and the trailing twelve-month operating margin stands at 18.11%. Profitability has been stable, with net margins hovering in the low-to-mid teens over recent quarters, reflecting the company's pricing power and operational efficiency in a competitive specialty chemicals industry. The balance sheet and cash flow position is robust but active. The debt-to-equity ratio is 0.97, indicating a moderate but manageable level of leverage. More importantly, the company generates substantial cash, with TTM free cash flow of $1.904 billion, providing ample internal funding for growth initiatives and the recently announced large acquisition. The return on equity of 21.24% is strong, demonstrating effective use of shareholder capital. The current ratio of 1.08 suggests adequate, though not excessive, short-term liquidity.

Quarterly Revenue

$4.2B

2025-12

Revenue YoY Growth

+0.04%

YoY Comparison

Gross Margin

+0.44%

Latest Quarter

Free Cash Flow

$1.9B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Global Institutional and Specialty
Global Life Sciences
Global Pest Elimination
Global Water

Open an Account, get $2 TSLA now!

Valuation Analysis: Is ECL Overvalued?

Given Ecolab's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 35.83x and a forward PE of 27.81x based on analyst estimates. The significant gap between trailing and forward multiples implies the market is pricing in expectations for substantial earnings growth in the coming year, partially driven by the acquisition. Compared to industry averages, Ecolab's valuation commands a premium. Its trailing PE of 35.83x and Price-to-Sales (PS) ratio of 4.62x are elevated relative to typical specialty chemical peers, which often trade at lower multiples. This premium is historically justified by Ecolab's market leadership, high-margin service model, and resilient revenue streams, though the recent acquisition adds uncertainty. Historically, the current trailing PE of 35.83x sits above the stock's own multi-year range observed in the historical ratios data, which has frequently fluctuated between the high 20s and low 40s. Trading near the higher end of its historical band suggests the market is already pricing in a relatively optimistic scenario for earnings growth and margin expansion, leaving less room for multiple expansion and increasing sensitivity to any earnings disappointments.

PE

35.8x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 25x~79x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

24.0x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: Ecolab's primary financial risk stems from its $4.75 billion acquisition of CoolIT, which, while funded from strong internal cash flow, represents a major capital allocation bet. Execution missteps could lead to margin dilution from the deal or goodwill impairment. The company operates with moderate leverage (Debt/Equity of 0.97), which is manageable but increases interest expense sensitivity in a higher-rate environment. While revenue is diversified across segments, the success of the new AI cooling initiative introduces a degree of concentration risk if it fails to meet growth expectations, potentially stalling the overall growth engine that justifies its 35.8x trailing PE.

Market & Competitive Risks: The most pressing market risk is valuation compression. Trading at a trailing PE of 35.83x, well above industry averages for specialty chemicals, the stock is vulnerable to multiple contraction if growth fails to accelerate as anticipated. The recent 13% discount to its 52-week high and weak relative strength indicate this process may already be underway. Competitive risks are heightened as Ecolab enters the AI data center cooling market, facing established players and rapid technological change. Furthermore, with a beta of 1.024, the stock is not a defensive safe haven and would be exposed to broader market downturns.

Worst-Case Scenario: The worst-case scenario involves a botched integration of CoolIT, leading to significant cost overruns, culture clashes, and a failure to capture meaningful market share in AI cooling. Concurrently, the core business could see margin pressure from inflation or a recessionary downturn in its industrial and hospitality end markets. This double blow would trigger analyst downgrades and a severe derating of the premium multiple. A realistic downside could see the stock re-testing its 52-week low of $235.93, representing a potential loss of approximately -12.5% from the current price of $269.49, with further downside possible if earnings estimates are cut.